February 5, 2015
Report co-author, Dr Mary Moran, and international key commentators discussed the report’s findings and health funding decisions for the future. The first G-FINDER Reproductive Health survey reported 2013 global investment into research and development (R&D) for new reproductive health products for developing countries. It covered investment for post-partum haemorrhage, contraceptives, non-HIV STIs, multipurpose prevention technologies and platform technologies. The G-FINDER Reproductive Health survey is conducted by the independent research group Policy Cures and is funded by the Bill & Melinda Gates Foundation. For more information regarding G-FINDER and Policy Cures, visit www.policycures.org or contact email@example.com.